Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness, cataplexy, and disrupted sleep, often underdiagnosed due to misinterpreted symptoms. The global treatment market is evolving with newer drugs like Wakix and Lumryz offering safer, more convenient options alongside pipeline innovations such as orexin receptor agonists. Growth will be driven by improved awareness and diagnosis, though challenges remain from generics and off-label prescribing.

This Datamonitor Healthcare report contains a Disease Analysis module.